Table 5.

Correlations between probiotic strains modulation of ROS production and clinical characteristics of PD patients.

Probiotic strain	Disease duration	H&Y stage	UPDRS III score	LED
LA02 (rho; p)	0.22; 0.002	0.18; 0.94	0.04; 0.55	0.03; 0.22
LP01	0.05; 0.19	−0.03; 0.53	0.07; 0.53	−0.01; 0.60
LR06	0.08; 0.88	−0.08; 0.83	−0.16; 0.40	0.06; 0.80
LS01	0.17; 0.61	0.25; 0.55	0.28; 0.63	0.05; 0.12
BR03	−0.01; 0.83	0.08; 0.84	−0.10; 0.88	0.01; 0.73
BS01	−0.05; 0.45	0.32; 0.21	0.06; 0.33	0.14; 0.48

Data are expressed as the value after probiotic strain exposure from a baseline conventionally established as 1. The statistically significant differences are shown in bold.